Man Group’s Maravai LifeSciences MRVI Stock Holding History

Man Group’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$989K	Buy	+158,429	New	+$684K	﹤0.01%	1860
2024 Q1	–	Sell	-50,569	Closed	-$331K	–	2219
2023 Q4	$331K	Buy	+50,569	New	+$327K	﹤0.01%	1788
2023 Q3	–	Sell	-27,370	Closed	-$301K	–	1763
2023 Q2	$340K	Buy	+27,370	New	+$369K	﹤0.01%	1690
2023 Q1	–	Hold	0	–	–	–	1678
2021 Q4	–	Sell	-22,450	Closed	-$1.1M	–	2048
2021 Q3	$1.1M	Buy	22,450 +10,943	+95%	+$534K	﹤0.01%	1317
2021 Q2	$481K	Sell	11,507 -9,731	-46%	-$377K	﹤0.01%	1570
2021 Q1	$757K	Buy	+21,238	New	+$704K	﹤0.01%	1366

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Man Group's MRVI Position: Q2 2026 in Review

Man Group opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 158,429 shares worth $989K. The stake represents ﹤0.01% of the portfolio and ranks #1860 among its holdings. This is a return to the name: Man Group previously reported a position in MRVI as recently as Q4 2023.

Man Group first reported a position in MRVI in Q1 2021 and has held it in 6 quarters since. The position peaked at $1.1M in Q3 2021. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Man Group held 158,429 shares of Maravai LifeSciences worth $989K as of Q2 2026.
Maravai LifeSciences was a new Man Group position in Q2 2026.
Maravai LifeSciences made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1860 holding.
Man Group first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 6 quarters since.
Man Group's Maravai LifeSciences position peaked at $1.1M in Q3 2021.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.